Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
Kim, K Jin
Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Feb 2006 - 1292-8 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1078-0432
10.1158/1078-0432.CCR-05-1793 doi
Animals
Antibodies, Monoclonal--immunology
Apoptosis--drug effects
Brain Neoplasms--pathology
Cell Line
Cell Line, Tumor
Cell Proliferation--drug effects
Dose-Response Relationship, Drug
Endothelial Cells--cytology
Female
Glioma--pathology
Hepatocyte Growth Factor--immunology
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
Mice, SCID
Neutralization Tests
Remission Induction
Time Factors
Xenograft Model Antitumor Assays--methods
Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Feb 2006 - 1292-8 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1078-0432
10.1158/1078-0432.CCR-05-1793 doi
Animals
Antibodies, Monoclonal--immunology
Apoptosis--drug effects
Brain Neoplasms--pathology
Cell Line
Cell Line, Tumor
Cell Proliferation--drug effects
Dose-Response Relationship, Drug
Endothelial Cells--cytology
Female
Glioma--pathology
Hepatocyte Growth Factor--immunology
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
Mice, SCID
Neutralization Tests
Remission Induction
Time Factors
Xenograft Model Antitumor Assays--methods